Filter Results
Clinical Studies
Results filtered:Study status:
Open
Closed for Enrollment
Closed for Enrollment
-
A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Pf-00547659 In Subjects with Crohn's Disease (Opera) (OPERA)
Jacksonville, Fla.
The purpose of this study is to assess the safety and effectiveness of PF-00547659 (experimental drug) for patients who have Crohn's disease that is clinically active despite conventional treatment.
-
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis (UNIFI)
Jacksonville, Fla.
The purpose of this study is to evaluate the effectiveness and safety of ustekinumab used as the initial treatment, given by IV, and as maintenance treatment, injected subcutaneously for patients who have moderately to severely active Ulcerative Colitis.
-
Use of Medication Therapy Management to Optimize Care Through Effective Resource Management in Inflammatory Bowel Disease
Rochester, Minn.,
Scottsdale/Phoenix, Ariz.,
Jacksonville, Fla.,
Eau Claire, Wis.,
Mankato, Minn.,
La Crosse, Wis.
The management of Inflammatory Bowel Disease (IBD) is complex and time consuming. While Current Procedural Terminology for MTM services are available they are under-utilized given the time constraints placed on practitioners trying to address multiple health care issues during a single visit. There are companies that specialize in patient pharmacy services to improve health care outcomes. Our aim is to utilize these services in a small number of IBD patients to assess effectiveness of such services within a tertiary care practice.
.